NAMS

NewAmsterdam Pharma Company N.V.

NAMS·N62509109·US·Common Stock·Healthcare - Biotechnology-Activist

NAMS (NewAmsterdam Pharma Company N.V.) is held by 111 institutional investors as of Q2 2026. Largest holders: Capital World Investors ($414.5M), FMR LLC ($350.4M), RA CAPITAL MANAGEMENT, L.P. ($323.7M). Net institutional sentiment: Mixed.

111
Holders
(10 Elite)
$2.4B
Total Value
66% (109)
Consensus
72 buying - 37 selling
13F: Insider & Congress: Updated regularly
NAMS

Smart Money Verdict

View all
Loading verdict
Held by 111 funds
10 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 25, 2026 · Activists Aug 6, 2026 · Congress none

InsiderKPKastelein Johannes Jacob PieterExercise 125K shAug 24, 2026
InsiderKPKastelein Johannes Jacob PieterSell $3.4MAug 24, 2026
ActivistFMR LLCFMR LLC8.8%Aug 6, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12.2M(+10.1%)$414.5M0.0%+12.21%
34
Increased
10.3M(+17.9%)$350.4M0.0%-3.55%
36
Unchanged
9.6M$323.7M2.8%+94.22%
0
Unchanged
4.2M$142.5M0.4%+148.29%
0
Increased
3.3M(+49.5%)$110.7M1.0%-0.57%
58
Decreased
2.1M(-23.6%)$71.2M0.0%+6.57%
0
New
1.7M$59.2M0.2%-19.15%
49
Decreased
1.7M(-39.1%)$58.4M0.1%+22.19%
0
Increased
1.7M(+19.6%)$58.4M0.0%+1.64%
35
Decreased
1.5M(-20.6%)$52.4M0.0%-5.54%
0
Decreased
1.5M(-30.3%)$52.1M0.2%-9.90%
0
Increased
1.4M(+31.5%)$46.5M0.2%-20.66%
44
Increased
1.3M(+66.5%)$42.5M0.0%-10.52%
43
Increased
1.3M(+5.0%)$40.3M0.0%+8.99%
31
Increased
1.1M(+28.1%)$38.4M0.0%+5.29%
36
Increased
1.1M(+31.8%)$37.4M0.1%+8.96%
37
Increased
1.1M(+20.0%)$36.1M0.0%-3.86%
34
Increased
993,917(+29.1%)$33.7M0.0%-6.83%
36
Decreased
781,140(-18.4%)$26.5M0.0%-12.21%
0
Increased
754,327(+4131.9%)$25.6M0.0%-18.74%
46

Showing 1-20 of 117

1 / 6
NAMSNAMSNewAmsterdam Pharma Company N.V.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used